Commentary on Gregory et al.: Fear of precipitated opioid withdrawal should not prevent buprenorphine initiation.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39494653.
- Also identified by DOI 10.1111/add.16701 and PMC identifier 11645183.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Provision of buprenorphine treatment for opioid use disorder is often stymied by clinicians’ concerns for precipitated opioid withdrawal. Gregory et al’s systematic review identified a low level of precipitated withdrawal with buprenorphine induction even among persons who reported fentanyl use. Evidence, not fear should guide treatment.